Cargando…

Neuropharmacology of New Psychoactive Substances (NPS): Focus on the Rewarding and Reinforcing Properties of Cannabimimetics and Amphetamine-Like Stimulants

New psychoactive substances (NPS) are a heterogeneous and rapidly evolving class of molecules available on the global illicit drug market (e.g smart shops, internet, “dark net”) as a substitute for controlled substances. The use of NPS, mainly consumed along with other drugs of abuse and/or alcohol,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Miliano, Cristina, Serpelloni, Giovanni, Rimondo, Claudia, Mereu, Maddalena, Marti, Matteo, De Luca, Maria Antonietta
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2016
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4835722/ https://www.ncbi.nlm.nih.gov/pubmed/27147945 http://dx.doi.org/10.3389/fnins.2016.00153

Ejemplares similares

Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps
por: Miliano, Cristina, et al.
Publicado: (2018)

EDITORIAL: New Psychoactive Substances (NPS), a New Global Issue: Neuropharmacological, Chemical and Toxicological Aspects
por: Pichini, Simona, et al.
Publicado: (2017)

Novel Psychoactive Substances—Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs
por: Hassan, Zurina, et al.
Publicado: (2017)

Herbal Highs: Review on Psychoactive Effects and Neuropharmacology
por: Graziano, Silvia, et al.
Publicado: (2017)

Four types of cannabimimetic indazole and indole derivatives, ADB-BINACA, AB-FUBICA, ADB-FUBICA, and AB-BICA, identified as new psychoactive substances
por: Qian, Zhenhua, et al.
Publicado: (2015)

The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS
por: Wadsworth, Elle, et al.
Publicado: (2018)

Novel Psychoactive Substances (NPS): a Study on Persian Language Websites
por: BIGDELI, Imanollah, et al.
Publicado: (2013)

Human Neuronal Cell Lines as An In Vitro Toxicological Tool for the Evaluation of Novel Psychoactive Substances
por: Sogos, Valeria, et al.
Publicado: (2021)

Suicidality and self-injury behaviours due to the use of Novel Psychoactive Substances (NPS)
por: Orsolini, L.
Publicado: (2023)

The Spicy Story of Cannabimimetic Indoles
por: Howlett, Allyn C., et al.
Publicado: (2021)

Hair analysis for New Psychoactive Substances (NPS): Still far from becoming the tool to study NPS spread in the community?
por: Florou, Dimitra, et al.
Publicado: (2021)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
por: Schifano, Fabrizio, et al.
Publicado: (2018)

Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon
por: Schifano, Fabrizio
Publicado: (2018)

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2020)

Amphetamines, new psychoactive drugs and the monoamine transporter cycle
por: Sitte, Harald H., et al.
Publicado: (2014)

The Role of Dopamine in the Stimulant Characteristics of Novel Psychoactive Substances (NPS)—Neurobiological and Computational Assessment Using the Case of Desoxypipradrol (2-DPMP)
por: Loi, Barbara, et al.
Publicado: (2020)

Corrigendum: Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2021)

Terpenoids, Cannabimimetic Ligands, beyond the Cannabis Plant
por: Gonçalves, Elaine C. D., et al.
Publicado: (2020)

The prevalence of novel psychoactive substances (NPS) use in non-clinical populations: a systematic review protocol
por: Khaled, Salma M., et al.
Publicado: (2016)

Psychoactive substances belonging to the amphetamine class potently activate brain carbonic anhydrase isoforms VA, VB, VII, and XII
por: Angeli, Andrea, et al.
Publicado: (2017)

Analyzing the Open/Deep Web to Better Understand the New/Novel Psychoactive Substances (NPS) Scenarios: Suggestions from CASSANDRA and NPS.Finder Research Projects
por: Schifano, Fabrizio
Publicado: (2020)

Rapid Detection and Quantification of Novel Psychoactive Substances (NPS) Using Raman Spectroscopy and Surface-Enhanced Raman Scattering
por: Muhamadali, Howbeer, et al.
Publicado: (2019)

Genotoxicity Evaluation of The Novel Psychoactive Substance MTTA
por: Lenzi, Monia, et al.
Publicado: (2023)

Differential effects of synthetic psychoactive cathinones and amphetamine stimulants on the gut microbiome in mice
por: Angoa-Pérez, Mariana, et al.
Publicado: (2020)

Clinical Presentations and Predictors of In-Hospital Mortality in Illicit Drug Users in the New Psychoactive Substances (NPS) Endemic Era in Taiwan
por: Yeh, Hsin-Tzu, et al.
Publicado: (2022)

Sex and Gender Differences in the Effects of Novel Psychoactive Substances
por: Fattore, Liana, et al.
Publicado: (2020)

Cannabis sativa terpenes are cannabimimetic and selectively enhance cannabinoid activity
por: LaVigne, Justin E., et al.
Publicado: (2021)

Repeated Use of the Psychoactive Substance Ethylphenidate Impacts Neurochemistry and Reward Learning in Adolescent Male and Female Mice
por: Robins, Meridith T., et al.
Publicado: (2019)

Mechanistic Insights into the Stimulant Properties of Novel Psychoactive Substances (NPS) and Their Discrimination by the Dopamine Transporter—In Silico and In Vitro Exploration of Dissociative Diarylethylamines
por: Sahai, Michelle A., et al.
Publicado: (2018)

Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project
por: Helander, Anders, et al.
Publicado: (2020)

Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications
por: Giorgetti, Arianna, et al.
Publicado: (2021)

Establishment of Neurotoxicity Assessment Using Microelectrode Array (MEA) with hiPSC-Derived Neurons and Evaluation of New Psychoactive Substances (NPS)
por: Kang, Kyu-ree, et al.
Publicado: (2022)

In Silico Investigations into the Selectivity of Psychoactive and New Psychoactive Substances in Monoamine Transporters
por: Botha, Michelle J., et al.
Publicado: (2022)

ANALYTICALLY CONFIRMED PRESENCE OF PSYCHOACTIVE SUBSTANCES, ESPECIALLY NEW PSYCHOACTIVE SUBSTANCES IN A GROUP OF PATIENTS HOSPITALIZED WITH MENTAL AND BEHAVIOURAL DISORDERS DUE TO THE USE OF PSYCHOACTIVE SUBSTANCES DIAGNOSIS
por: Engelgardt, Piotr, et al.
Publicado: (2022)

Neuropharmacology
por: Rosner, Burton S.
Publicado: (1956)

Neuropharmacology
por: Glaser, Gilbert H.
Publicado: (1958)

Neuropharmacology
por: Giarman, Nicholas J.
Publicado: (1959)

Neuropharmacology
por: Giarman, Nicholas J.
Publicado: (1961)

Neuropharmacology
Publicado: (2008)

Analysis of Relationships between DAT1 Polymorphism Variants, Personality Dimensions, and Anxiety in New Psychoactive Substance (Designer Drug) (NPS) Users
por: Chmielowiec, Jolanta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_edc8t9tdq969j6pgk0p846b38q